Luka Dončić Is Closing Fast on Wembanyama in the MVP Race

Victor Wembanyama still sits atop the 2026-27 NBA MVP conversation, but Luka Dončić is no longer a distant threat. The money that sets prices on next season's award has shifted meaningfully in Dončić's direction over the past day, turning what is already a wide-open race into something that looks increasingly like a two-man fight at the top.

Wembanyama leads at 35%, a probability that has climbed from a low of 22% just one week ago — a recovery that reflects genuine conviction in the young San Antonio center's trajectory. Yet 35% in a field this fractured is a plurality, not a grip. Dončić now commands 29%, the biggest single-day move of any contender, and the gap between the two is narrow enough that a single strong stretch of play, a trade, or an injury scare could flip the order. The odds favor no one in the way a true front-runner is favored; they favor the race staying fluid.

The deeper signal here is what the broader set of NBA markets implies about where power will sit next season. San Antonio is priced at 23% to win the NBA Finals — a legitimate contender's number, not a long shot's — which means bettors aren't just pricing Wembanyama as a statistical phenomenon. They believe his team will be in the conversation for a championship, the kind of context that produces MVP winners. Dončić, meanwhile, has historically thrived when his supporting cast is rebuilt around him, and any roster news out of Dallas this offseason will land directly on his MVP odds.

Shai Gilgeous-Alexander and Nikola Jokić have both drifted in the past day, falling to 11% and 8% respectively. That money went somewhere, and the likeliest destination is the top of the board. The pattern across the related markets points to bettors consolidating around fewer names rather than spreading risk — a sign that informed participants think they know roughly who the real contenders are, even if they disagree on which one wins.

It is worth noting that Kalshi, the deeper market on Jayson Tatum's individual contract by roughly two-to-one in today's volume, prices him at 8% — double Polymarket's 4% read. That divergence doesn't change the top of the race, but it illustrates how much genuine uncertainty still exists even for players further down the board. When two liquid venues disagree that sharply on the same question, it typically means the market hasn't yet found a consensus, not that one venue is obviously right.

What would break the current consensus? A Wembanyama injury or a slow start would reprice the race overnight — at 35%, he carries the most downside exposure of any single name. Dončić surging past him would require either a Dallas resurgence or a Wembanyama stumble, and the money currently treats both as real possibilities rather than remote ones. The path most consistent with today's pricing is a season-long duel between the two, with Wembanyama holding a modest edge that the rest of the league spends nine months trying to erase.

For fans and front offices alike, the relevant takeaway is that the MVP award next season appears increasingly likely to be decided by durability and team success as much as individual brilliance. In a race this open, the winner may well be the player who simply stays healthy and keeps his team winning deep into March.